Common Contracts
3 similar Common Stock Purchase Agreement contracts by Alexza Pharmaceuticals Inc., Jones Soda Co, Pharmacyclics Inc
COMMON STOCK PURCHASE AGREEMENT Dated as of June 11, 2010 by and between JONES SODA CO. and GLENGROVE SMALL CAP VALUE, LTD.Common Stock Purchase Agreement • June 14th, 2010 • Jones Soda Co • Beverages • New York
This COMMON STOCK PURCHASE AGREEMENT, made and entered into on this 11th day of June, 2010 (this “Agreement”), by and between Glengrove Small Cap Value, Ltd., a business company incorporated under the laws of the British Virgin Islands (the “Investor”), and Jones Soda Co., a corporation organized and existing under the laws of the State of Washington (the “Company”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in Annex A hereto.
COMMON STOCK PURCHASE AGREEMENT Dated as of May 26, 2010 by and between ALEXZA PHARMACEUTICALS, INC. and AZIMUTH OPPORTUNITY LTD.Common Stock Purchase Agreement • May 26th, 2010 • Alexza Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
This COMMON STOCK PURCHASE AGREEMENT, made and entered into on this 26 day of May 2010 (this “Agreement”), by and between Azimuth Opportunity Ltd., an international business company incorporated under the laws of the British Virgin Islands (the “Investor”), and Alexza Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”). Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in Annex A hereto.
COMMON STOCK PURCHASE AGREEMENT Dated August 21, 2006 by and between PHARMACYCLICS, INC. and AZIMUTH OPPORTUNITY LTD.Common Stock Purchase Agreement • August 21st, 2006 • Pharmacyclics Inc • Pharmaceutical preparations • New York
This COMMON STOCK PURCHASE AGREEMENT, made and entered into on this 21st day of August 2006 (this “Agreement”), by and between Azimuth Opportunity Ltd., an international business company incorporated under the laws of the British Virgin Islands (the “Investor”), and Pharmacyclics, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”).
